Riskpilot← Back to searchSign inGet full accessApotekmax AB
ABActiveOrg 5593058109Vasagatan 11Other non-specialised retail sale · NACE 4712Est. 20211 employees
Revenue 2024
SEK 9K
-56% vs 2023
EBITDA margin
-477.0%
-309% vs 2023
Equity ratio
-383.2%
Financial strength
Net profit 2024
SEK -42K
1 employees
| Revenue | SEK 9K | -56% |
| EBITDA | SEK -44K | -309% |
| Net profit | SEK -42K | — |
| Total assets | SEK 112K | +0% |
| Equity | SEK -427K | -11% |
| Employees | 1 | — |
Legal name
Apotekmax AB
Org number
5593058109
Legal form
Aktiebolag
NACE code
4712 · Other non-specialised retail sale
Founded
5 mars 2021
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget erbjuder omfattande och individanpassade vård- och omsorgstjänster för personer med funktionsnedsättningar, inklusive personlig assistans. Dessutom specialiserar vi oss på försäljning av receptfria läkemedel, hälsoprodukter och kosttillskott. Vi erbjuder även professionella godstransport- tjänster inom Sverige. Vi bedriver också konsultverksamhet inom receptfria läkemedel, hudvårdsprodukter. Vårt mål är att hjälpa småföretag att öka sin försäljning.
Address
Vasagatan 11
Email
info@apotekmax.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | −1 | 21 | 9 |
| Staff expenses | — | −0 | — | — |
| EBITDA | — | −164 | 21 | −44 |
| Depreciation & amort. | −0 | — | — | — |
| EBIT | 0 | −164 | — | −44 |
| Net financials | — | 0 | — | 2 |
| Profit before tax | 0 | −164 | — | −42 |
| Tax | −0 | — | — | — |
| Net profit | 0 | −164 | — | −42 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 200 | 85 | 112 | 112 |
| Equity | 25 | −139 | −385 | −427 |
| Long-term debt | 175 | 173 | 171 | 171 |
| Short-term debt | 0 | 51 | 326 | 368 |
| Total debt | 175 | 224 | 497 | 539 |
EBITDA margin
-477.0%
This company
15.8%
Market median
-3119% vs market
20212024
Equity ratio
-383.2%
This company
38.2%
Market median
-1103% vs market
20212024
Return on equity
-4210200.0%
This company
18.4%
Market median
-22881622% vs market
20212024
Net profit margin
-457.1%
This company
8.1%
Market median
-5743% vs market
20212024
Asset turnover
0.08×
This company
1.12×
Market median
-93% vs market
20212024
Debt / equity
1.26×
This company
0.62×
Market median
-103% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-03-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SA Chief Executive Officer | Chief Executive Officer | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2025 | |
| Former (2) | ||
| Deputy Board Member | 2022 – 2025 | |
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Apotekmax AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Salwan Aziz Suleiman | Chief Executive Officer | 0 companies |
| Salman Aziz Sulaiman | Deputy Board Member | 0 companies |
| Aziz Suleiman Yohanna | Deputy Board Member | 0 companies |
| Salman Abd Alazez Sulaiman | Deputy Board Member | 0 companies |